A conceptual model for advanced/metastatic gastric or gastroesophageal junction cancer: a review of qualitative studies and results from patient interviews

A conceptual model for advanced/metastatic gastric or gastroesophageal junction cancer: a review of qualitative studies and results from patient interviews

Abstract Background Despite approvals of new first-line immunotherapies for advanced/metastatic gastric cancer/gastroesophageal junction cancer (aGC/GEJC), patients’ median survival is around 14 months and their health-related quality of life (HRQoL) is affected by disease-related symptoms and treat...

Full description

Saved in:

Bibliographic Details
Main Authors:	France Ginchereau Sowell, Thom de Milliano, Keri J. S. Brady, Ginamarie Foglia, Medha Sasane, Samira Bensfia, Matthew Reaney
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	BMC Cancer
Subjects:	Advanced/metastatic gastric cancer/Gastroesophageal junction cancer Conceptual model Gastric cancer Gastroesophageal junction cancer Health-related quality of life Patient experience data
Online Access:	https://doi.org/10.1186/s12885-025-13474-9
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of pembrolizumab in advanced gastric and gastroesophageal junction cancer: a systematic review and meta-analysis
by: Xiaoying Ji, et al.
Published: (2025-03-01)

Efficacy and safety of Nivolumab in advanced gastric and gastroesophageal junction cancer: a meta-analysis of randomized controlled trials
by: Xinming Lei, et al.
Published: (2024-11-01)

Trastuzumab deruxtecan in patients from China with previously treated human epidermal growth factor receptor 2–positive locally advanced/metastatic gastric or gastroesophageal junction adenocarcinoma (DESTINY-Gastric06): results from a single-arm, multicenter, phase 2 trialResearch in context
by: Zhi Peng, et al.
Published: (2025-09-01)

Deciphering the dual role of autophagy in gastric cancer and gastroesophageal junction cancer: from tumor suppression to cancer progression
by: Lili Lei, et al.
Published: (2025-06-01)

Case report: Patients with positive HER-2 amplification locally advanced gastroesophageal junction cancer achieved pathologic complete response with the addition of pembrolizumab to chemotherapy plus trastuzumab as neoadjuvant therapy
by: Huanhuan Li, et al.
Published: (2025-02-01)

First-line immune checkpoint inhibitors with chemotherapy in advanced gastric and gastroesophageal junction adenocarcinoma: a meta-analysis of phase 3 trials
by: Yuxuan Lin, et al.
Published: (2025-05-01)

Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population‐based study
by: Panpan Zhang, et al.
Published: (2018-09-01)

Discussion on the mechanism of HER2 resistance in esophagogastric junction and gastric cancer in the era of immunotherapy
by: Yan Zhang, et al.
Published: (2025-12-01)

Efficacy and safety of programmed cell death protein-1 inhibitor for first-line therapy of advanced gastric or gastroesophageal junction cancer: a network meta-analysis
by: Yunnan Zhang, et al.
Published: (2025-04-01)

Neoadjuvant PD-1/PD-L1 inhibitors combined with chemotherapy in gastric cancer and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis of single-arm studies
by: Jun Leng, et al.
Published: (2025-08-01)

Evaluation of Conventional Treatment Planning Techniques for Radiotherapy of Gastroesophageal Junction Cancer: A Dosimetric Comparison between Male and Female Patients
by: Mohamad Pursamimi, et al.
Published: (2025-03-01)

DNA methylation markers for sensitive detection of circulating tumor DNA in patients with gastroesophageal cancers
by: N. Øgaard, et al.
Published: (2024-12-01)

Evaluating survival outcomes and treatment recommendations in resectable gastric cancer
by: Saad Sabbagh, et al.
Published: (2025-01-01)

Kyoto International Consensus Report on Anatomy, Pathophysiology and Clinical Significance of the Gastroesophageal Junction
by: A. A. Sheptulin, et al.
Published: (2023-12-01)

Total neoadjuvant chemotherapy according to the FOLFIRINOX regimen for locally advanced adenocarcinoma of the stomach and cardioesophageal junction: interim results
by: M. V. Sedova, et al.
Published: (2023-09-01)

Primary malignant melanoma of the gastroesophageal junction with KIT gene exon 11 mutation
by: Xiaozhuo Gao, et al.
Published: (2024-06-01)

Impact of Tregs on tumor regression in locally advanced G/GEJ cancer patients undergoing neoadjuvant chemoimmunotherapy
by: Yong Zhang, et al.
Published: (2025-08-01)

Conversion surgery for stage IV gastric cancer after third-line immunotherapy: a case report
by: Sevindzh F. Evdokimova, et al.
Published: (2024-12-01)

A Canadian algorithm for upper gastrointestinal cancer management
by: Frédéric Lemay, et al.
Published: (2025-04-01)

Eligibility and workload implications of adjuvant immunotherapy in patients with resected esophageal and gastroesophageal junction (ESO/GEJ) cancer
by: T.H. Lee, et al.
Published: (2025-03-01)

Cost-effective analysis of sugemalimab plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma with PD-L1 CPS ≥5
by: Yalan Zhang, et al.
Published: (2025-08-01)

Cadonilimab in combination with chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a cost-effectiveness analysis
by: Zuojuan Xiang, et al.
Published: (2025-07-01)

Cost-effectiveness analysis of first-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma
by: Zhifeng Zhou, et al.
Published: (2025-05-01)

A case report and analysis of skin metastasis of adenocarcinoma of gastroesophageal junction and its therapeutic outcome
by: LI Hao, DENG Jin, LIU Peihua, ZHANG Quanyong, CAI Zhai
Published: (2025-06-01)

The expression of the tight junction protein and therapeutical target Claudin 18.2 is heterogeneously distributed within esophageal and gastric adenocarcinoma
by: Svetlana Pak, et al.
Published: (2025-08-01)

Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review
by: Genlin Lu, et al.
Published: (2025-01-01)

Prognostic factors and treatment response in HER2-positive gastric cancer patients receiving trastuzumab deruxtecan: secondary analysis of the EN-DEAVOR study
by: K. Nakanishi, et al.
Published: (2025-06-01)

The role of multispiral computed tomography in detecting and the assessment of the degree of damage of esophago-gastric junction cancer
by: V. N. Diomidova, et al.
Published: (2022-03-01)

Comparison among Early-Onset, Late-Onset, and Conventional-Onset Adenocarcinoma of Stomach and Esophagogastric Junction: a Retrospective Study
by: Yidi Liang, et al.
Published: (2025-06-01)

Gastroesophageal reflux disease in patients with morbid obesity
by: A. S. Lavryk, et al.
Published: (2022-02-01)

Comparison of the safety of esophagojejunal overlap and π-shaped anastomosis in totally laparoscopic total gastrectomy
by: Tongkun Song, et al.
Published: (2025-01-01)

Rare Gastric Metastasis From Cervical Cancer: A Case Report
by: Fariha Hasan, et al.
Published: (2025-02-01)

A Systematic Review and Meta-Analysis on the Prevalence of Variants in the Pancreaticobiliary Duct Junction and Its Association with Cancer
by: Juan José Valenzuela-Fuenzalida, et al.
Published: (2025-04-01)

Digital pathology-based artificial intelligence model to predict microsatellite instability in gastroesophageal junction adenocarcinomas
by: Zhenqian Li, et al.
Published: (2025-08-01)

Laparoscopic curative resection following perioperative chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel and its influence on Claudin18.2 expression in advanced gastric or gastroesophageal junction adenocarcinoma: a two-case report
by: Tohru Takahashi, et al.
Published: (2025-04-01)

Gastroesophageal reflux disease in children including palliative pediatric patients
by: Yu. Yu. Razuvaeva, et al.
Published: (2023-07-01)

Efficacy of the U‐shaped flap technique in preventing reflux after minimally invasive proximal gastrectomy for proximal gastric and esophagogastric junction cancer
by: Takeshi Omori, et al.
Published: (2025-03-01)

Synergistic effects of PD-1 antibody and chemotherapy followed by surgery-centric local treatment in patients with limited-metastatic gastric or gastroesophageal adenocarcinoma (ROSETTE trial): an open-label, single-center, randomized phase 2 trial
by: Ying Ying Wu, et al.
Published: (2025-06-01)

Morpho-functional aspects of mutual influence of bronchial asthma and gastroesophageal reflux
by: R. I. Pleshko, et al.
Published: (2005-12-01)

Correlation between cough and gastroesophageal reflux in children
by: A. V. Burlutskaya, et al.
Published: (2022-09-01)